The recent development of clinical trials testing combination therapies should be embraced as an important trend in AD drug development [30] . 2.5.
← all excerpts
Neuroscience learning from longitudinal cohort studies of Alzheimer's disease: Lessons for disease-modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience.
1
—
—